+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Glycomics/Glycobiology Market by Product Type, Applications, End-User - Global Forecast to 2030- Product Image
Glycomics/Glycobiology Market by Product Type, Applications, End-User - Global Forecast to 2030- Product Image
Sale

Glycomics/Glycobiology Market by Product Type, Applications, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674276
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The glycomics/glycobiology market is rapidly evolving, driven by technological advancements and expanding applications in life sciences, diagnostics, and therapeutics. Senior decision-makers are now prioritizing actionable insights and reliable data to inform strategic planning, risk management, and investments across this growing sector.

Market Snapshot: Glycomics/Glycobiology Market Outlook

The glycomics/glycobiology market expanded from USD 1.54 billion in 2024 to USD 1.76 billion in 2025, with a compound annual growth rate (CAGR) of 16.46% projected to drive the market to USD 3.84 billion by 2030. This strong trajectory signals heightened demand for glycan analysis, advanced instrumentation, and integrated solutions among pharmaceutical, biotechnology, and research organizations. The outlook reflects both the sector’s innovation capacity and the increasing relevance of glycomics in next-generation biomedical development, clinical diagnostics, and precision medicine.

Scope & Segmentation of the Glycomics/Glycobiology Market

  • Product Types: Enzymes (glycosidases, neuramidases, glycosyltransferases, sialyltransferases, protein sulfotransferases, sulfatases), Instruments (arrays, chromatography systems, electrophoresis units, HPLC columns, mass spectrometry platforms), Kits (glycan labeling, purification, glycoprotein labeling), and Reagents & Chemicals.
  • Applications: Diagnostics (cancer detection, genetic disorders, infectious diseases), Therapeutics (drug delivery systems, drug development, drug discovery).
  • End-User Segments: Academic research institutes, contract research organizations, pharmaceutical and biotechnology companies.
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies Profiled: Agilent Technologies, AMSBIO, Asparia Glycomics, Bio-Techne Corporation, Bruker Corporation, Chemily Glycoscience, Creative Diagnostics, FUJIFILM Wako Pure Chemical Corporation, Genos Glyco, Glycan Therapeutics, GlycoDiag, glyXera GmbH, ICE S.p.a., Lectenz Bio, Ludger Ltd, Megazyme Ltd. by Neogen Corporation, Merck KGaA, New England Biolabs, QIAGEN N.V., RayBiotech, Revvity, SCIEX by Danaher Corporation, Shimadzu Corporation, Sumitomo Bakelite, Takara Bio, Thermo Fisher Scientific, Tokyo Chemical Industry Co., Vector Laboratories, Waters Corporation, Z Biotech, Zacharon Pharmaceuticals.

Key Takeaways for Senior Decision-Makers

  • High adoption of integrated analytical platforms is reshaping workflows, increasing automation, throughput, and reducing turnaround times for glycan analyses.
  • AI-driven informatics and cloud-based data tools are enabling seamless collaboration, faster interpretation, and more reproducible results across global research teams.
  • Strategic partnerships among instrument providers, software developers, and academic consortia are accelerating standardization and regulatory alignment, supporting broader clinical application.
  • End-user needs vary: academic institutes emphasize methodological innovation, CROs require scalable and validated platforms, and pharma/biotech demand integrated solutions for bench-to-clinic translation.
  • Regional trends highlight rapid adoption in Asia-Pacific, the established ecosystem in North America, and strategic investments in biotech clusters within EMEA.
  • Merger and acquisition activities, alongside the entry of niche innovators offering specialized enzymes, labeling kits, and reagents, are intensifying competitive dynamics and expanding solution portfolios.

Tariff Impact: Navigating US Trade Policy Adjustments

The introduction of revised US tariffs in 2025 has reshaped procurement strategies and cost structures, particularly for key enzymes and reagents sourced globally. Market participants are reassessing supplier relationships, increasing regional diversification, and investing in domestic manufacturing to manage higher import duties and logistics disruptions. Supply chain agility and collaborative sourcing are emerging as critical levers for maintaining cost control and research continuity in this evolving landscape.

Market Research Methodology & Data Sources

This research utilizes a rigorous approach that blends primary interviews with academic leaders, CROs, and industry experts, alongside secondary sources such as peer-reviewed journals, patent and regulatory databases, and trade filings. Comprehensive cross-validation and structured segmentation underpin data integrity and actionable analysis.

Why This Report Matters for Strategic Planning

  • Equips decision-makers with validated, forward-looking insights on technological shifts and evolving regulatory frameworks in glycomics/glycobiology.
  • Supports informed investment, procurement, and partnership decisions by highlighting emerging risks, regional opportunities, and innovation imperatives.
  • Enables effective benchmarking of leading market players, capturing both established and niche innovators shaping industry direction.

Conclusion: Actionable Guidance for Market Stakeholders

This report offers a robust foundation for steering growth, mitigating supply chain risks, and capturing emerging opportunities across the global glycomics market. It empowers senior leaders to align technology, procurement, and partnership strategies for sustainable competitiveness and innovation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Glycomics/Glycobiology Market, by Product Type
8.1. Introduction
8.2. Enzymes
8.2.1. Glycosidases & Neuramidases
8.2.2. Glycosyltransferases & Sialytransferases
8.2.3. Protein Sulfotransferases & Sulfatases
8.3. Instruments
8.3.1. Arrays
8.3.2. Chromatography Instruments
8.3.3. Electrophoresis Instruments
8.3.4. HPLC Columns
8.3.5. Mass Spectrometry Instruments
8.4. Kits
8.4.1. Glycan Labeling Kits
8.4.2. Glycan Purification Kits
8.4.3. Glycoprotein Labeling Kits
8.5. Reagents & Chemicals
9. Glycomics/Glycobiology Market, by Applications
9.1. Introduction
9.2. Diagnostics
9.2.1. Cancer Detection
9.2.2. Genetic Disorders
9.2.3. Infectious Diseases
9.3. Therapeutics
9.3.1. Drug Delivery Systems
9.3.2. Drug Development
9.3.3. Drug Discovery
10. Glycomics/Glycobiology Market, by End-User
10.1. Introduction
10.2. Academic Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Glycomics/Glycobiology Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Glycomics/Glycobiology Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Glycomics/Glycobiology Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Agilent Technologies, Inc.
14.3.2. AMSBIO
14.3.3. Asparia Glycomics
14.3.4. Bio-Techne Corporation
14.3.5. Bruker Corporation
14.3.6. Chemily Glycoscience
14.3.7. Creative Diagnostics
14.3.8. FUJIFILM Wako Pure Chemical Corporation
14.3.9. Genos Glyco
14.3.10. Glycan Therapeutics
14.3.11. GlycoDiag
14.3.12. glyXera GmbH
14.3.13. ICE S.p.a.
14.3.14. Lectenz Bio, Inc.
14.3.15. Ludger Ltd
14.3.16. Megazyme Ltd. by Neogen Corporation
14.3.17. Merck KGaA
14.3.18. New England Biolabs, Inc.
14.3.19. QIAGEN N.V.
14.3.20. RayBiotech, Inc.
14.3.21. Revvity, Inc.
14.3.22. SCIEX by Danaher Corporation
14.3.23. Shimadzu Corporation
14.3.24. Sumitomo Bakelite Co., Ltd.
14.3.25. Takara Bio Inc.
14.3.26. Thermo Fisher Scientific Inc.
14.3.27. Tokyo Chemical Industry Co., Ltd.
14.3.28. Vector Laboratories, Inc.
14.3.29. Waters Corporation
14.3.30. Z Biotech, LLC
14.3.31. Zacharon Pharmaceuticals, Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. GLYCOMICS/GLYCOBIOLOGY MARKET MULTI-CURRENCY
FIGURE 2. GLYCOMICS/GLYCOBIOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. GLYCOMICS/GLYCOBIOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLYCOMICS/GLYCOBIOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. GLYCOMICS/GLYCOBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GLYCOMICS/GLYCOBIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSIDASES & NEURAMIDASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSYLTRANSFERASES & SIALYTRANSFERASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PROTEIN SULFOTRANSFERASES & SULFATASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ELECTROPHORESIS INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY HPLC COLUMNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN LABELING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN PURIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOPROTEIN LABELING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REAGENTS & CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CANCER DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 60. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 61. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 62. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 63. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 64. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 65. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 68. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 72. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 109. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 110. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 111. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 112. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 113. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 114. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 117. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 119. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 120. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 121. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 122. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 133. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 134. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 135. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 136. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 137. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 138. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 141. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 142. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 143. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 144. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 145. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 146. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 173. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 174. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 175. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 176. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 177. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 178. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 189. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 190. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 191. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 192. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 193. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 194. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 197. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 199. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 200. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 201. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 202. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 221. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 222. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 223. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 224. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 225. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 226. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 229. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 230. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 231. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 232. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 233. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 234. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 245. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 247. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 248. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 249. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 250. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 253. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 254. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 255. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 256. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 257. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 258. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 276. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 278. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 279. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 280. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 281. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 282. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 283. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 286. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 287. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 288. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 289. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 290. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 291. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 292. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 294. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 295. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 296. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 297. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 298. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 299. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 323. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 324. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 325. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 326. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 327. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 328. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 329. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 330. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 331. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 339. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Glycomics/Glycobiology market report include:
  • Agilent Technologies, Inc.
  • AMSBIO
  • Asparia Glycomics
  • Bio-Techne Corporation
  • Bruker Corporation
  • Chemily Glycoscience
  • Creative Diagnostics
  • FUJIFILM Wako Pure Chemical Corporation
  • Genos Glyco
  • Glycan Therapeutics
  • GlycoDiag
  • glyXera GmbH
  • ICE S.p.a.
  • Lectenz Bio, Inc.
  • Ludger Ltd
  • Megazyme Ltd. by Neogen Corporation
  • Merck KGaA
  • New England Biolabs, Inc.
  • QIAGEN N.V.
  • RayBiotech, Inc.
  • Revvity, Inc.
  • SCIEX by Danaher Corporation
  • Shimadzu Corporation
  • Sumitomo Bakelite Co., Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • Vector Laboratories, Inc.
  • Waters Corporation
  • Z Biotech, LLC
  • Zacharon Pharmaceuticals, Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.76 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.84 Billion
Compound Annual Growth Rate16.4%
Regions CoveredGlobal
No. of Companies Mentioned32

Related Topics

Related Reports

Glycomics Or Glycobiology Market Report 2025 - Product Image

Glycomics Or Glycobiology Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Glycomics / Glycobiology - Global Strategic Business Report - Product Image

Glycomics / Glycobiology - Global Strategic Business Report

  • Report
  • 249 Pages
  • Global
From
Glycomics Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033 - Product Image

Glycomics Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033

  • Report
  • 134 Pages
  • Global
From
Translational Glycobiology in Human Health and Disease - Product Image

Translational Glycobiology in Human Health and Disease

  • Book
Chemical Glycobiology: Monitoring Glycans and Their Interactions. Methods in Enzymology Volume 598 - Product Image

Chemical Glycobiology: Monitoring Glycans and Their Interactions. Methods in Enzymology Volume 598

  • Book
Copyright © 2002-2025 Research and Markets. All Rights Reserved.